Harshbarger, Diana
☆Alerts · when they speak
Get an alert the moment Harshbarger, Diana speaks on the record.
Start free →
60%
spoke · 3 of 5 transcribed hearings
5min
speaking time on the record
23
speaking turns
1,046
words on the record
Talks about
okay
On the record
Rep. Harshbarger's own words —
✓ VALIDATED
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
Jul 15, 2026
73:52
Harshbarger, Diana. Yeah, absolutely. I agree with everything. One point that stood out in your testimony, sir, was the limited number of FDA inspections conducted in China, and I have 11 seconds left. But if FDA cannot routinely inspect foreign trial sites, how confident should Americans be in relying heavily on that ...
Committee activity
10 recent
HSE
Markup of Sixteen Bills
HSE
Nuclear Spent Fuel Policy: Examining Nuclear Lifecycle Innovation Campuses
HSE
“Examining Legislative Proposals to Reform Medicare Provider Payment and Bolster Health Care Cybersecurity.”
HSE
Ten Pieces of Legislation
HSE
Full Committee Markup of Twenty-Nine Pieces of Legislation
HSE
● SPOKEMaintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
HSE
Three Pieces of Legislation
HSE
● SPOKESubcommittee Markup of Six Pieces of Legislation
HSE
Nine Pieces of Legislation
HSE
● SPOKEState Medicaid Program Integrity: Examining Fraud Risks and Oversight Deficiencies.